Cardiac Insight, a leading ECG medical device company headquartered in Bellevue, Washington, is proud to introduce the Cardea 20/20 ECG, a groundbreaking solution that can be used for checking athlete’s hearts or…a groundbreaking solution with specialized ECG criteria for an athlete’s heart.
Developed by Dr. Dave Hadley, Chief Technology Officer at Cardiac Insight, and Dr. Vic Frolicher, Professor of Medicine and Consultant in Sports Cardiology at Stanford Healthcare, the Cardea 20/20 ECG represents a leap forward in cardiac health technology.
Key Features of the Cardea 20/20 ECG:
- Breakthrough Interpretive Algorithms: The Cardea 20/20 with International Criteria enables physicians to identify difficult-to-diagnose cardiac abnormalities, potentially preventing Sudden Cardiac Arrest (SCA).
- Developed by Experts: Dr. Dave Hadley and Dr. Vic Frochlicher, leading authorities in the field, were instrumental in developing the Cardea 20/20 ECG.
- Lowest False Positive Rate: With a false positive rate of ~2%, compared to the industry norm of up to 30%, the 20/20 utilizes the International Criteria, an evidence-based analysis that guides physician’s ECG interpretation of the athletic heart.
- Immediate Automated Interpretation: Offering onsite testing with immediate automated interpretation, the device provides a quick and accurate analysis of an athlete’s heart health once over-read and confirmed by a clinician.
Exclusive Interview Opportunity:
Cardiac Insight invites media members to gain exclusive insight into the development and impact of the Cardea 20/20 ECG through interviews with Dr. Dave Hadley and Dr. Vic Frochlicher. This unique opportunity will highlight the critical issue of cardiac health in athletes and showcase the passion and expertise behind this groundbreaking technology.
About Cardiac Insight:
Cardiac Insight is a Seattle-based ECG medical device company dedicated to developing innovative solutions for cardiac health. With a focus on athlete-specific needs, the company’s flagship product, the Cardea 20/20 ECG, is a testament to its commitment to preventing Sudden Cardiac Arrest and improving heart health outcomes.
Please find the attached press release and a video showcasing the Cardea 20/20 ECG in action.